Bio Green Med Solution Statistics
Total Valuation
BGMS has a market cap or net worth of $8.13 million. The enterprise value is $4.30 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BGMS has 4.90 million shares outstanding. The number of shares has increased by 7,630.22% in one year.
| Current Share Class | 4.90M |
| Shares Outstanding | 4.90M |
| Shares Change (YoY) | +7,630.22% |
| Shares Change (QoQ) | +118.34% |
| Owned by Insiders (%) | 55.40% |
| Owned by Institutions (%) | 0.03% |
| Float | 1.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.24 |
| Forward PS | 318.99 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 53.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.43, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.43 |
| Quick Ratio | 4.55 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -177.57% and return on invested capital (ROIC) is -187.02%.
| Return on Equity (ROE) | -177.57% |
| Return on Assets (ROA) | -84.69% |
| Return on Invested Capital (ROIC) | -187.02% |
| Return on Capital Employed (ROCE) | -128.19% |
| Revenue Per Employee | $6,750 |
| Profits Per Employee | -$581,167 |
| Employee Count | 12 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BGMS has paid $1.20 million in taxes.
| Income Tax | 1.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.27% in the last 52 weeks. The beta is -0.18, so BGMS's price volatility has been lower than the market average.
| Beta (5Y) | -0.18 |
| 52-Week Price Change | -98.27% |
| 50-Day Moving Average | 2.71 |
| 200-Day Moving Average | 24.57 |
| Relative Strength Index (RSI) | 44.83 |
| Average Volume (20 Days) | 87,560 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BGMS had revenue of $81,000 and -$6.97 million in losses. Loss per share was -$6.73.
| Revenue | 81,000 |
| Gross Profit | -1.66M |
| Operating Income | -9.17M |
| Pretax Income | -4.24M |
| Net Income | -6.97M |
| EBITDA | -9.17M |
| EBIT | -9.17M |
| Loss Per Share | -$6.73 |
Full Income StatementBalance Sheet
The company has $3.84 million in cash and $5,000 in debt, giving a net cash position of $3.83 million or $0.78 per share.
| Cash & Cash Equivalents | 3.84M |
| Total Debt | 5,000 |
| Net Cash | 3.83M |
| Net Cash Per Share | $0.78 |
| Equity (Book Value) | 7.10M |
| Book Value Per Share | 2.03 |
| Working Capital | 5.44M |
Full Balance SheetCash Flow
| Operating Cash Flow | -6.09M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.09M |
| FCF Per Share | -$1.24 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -11,324.69% |
| Pretax Margin | -5,238.27% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |